Editorial
We are thrilled to recognize these young investigators and the chances they took. Their projects highlight a virtuous cycle: new biological insights often require fresh perspectives, and fresh perspectives can be won by taking risks.
In fact, sometimes it is possible to take scientific risks without performing a study at all. For example, Johan Elf (325-327) proposes a hypothesis for how homologous sequences ''find'' each other inside the cell, a question of central importance for understanding homologous recombination and improving CRISPR-Cas-mediated gene editing. Hint: it may involve a ''parallel search'' process. We applaud the intellectual risk inherent in sharing untested ideas with the broader research community.
Risk takes many forms. Questioning the foundational ideas of a field, collaborating across disciplines in non-standard ways, developing technology or approaches that are new to biology, or tackling dramatically different problems at different stages of one's career are but a few ways to take scientific risks. Historically, risk taking has facilitated fundamental discoveries, and it can be argued that a more conservative approach to science has unfortunately dominated US biomedical research in recent years. These are weighty issues indeed, beyond of the remit of a single journal. But journals like ours can demonstrate what we find to be valuable by rewarding risk in and beyond our pages. 
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